Cargando...
Metastatic triple-negative breast cancer is dependent on SphKs/S1P signaling for growth and survival
About 40,000 American women die from metastatic breast cancer each year despite advancements in treatment. Approximately, 15% of breast cancers are triple-negative for estrogen receptor, progesterone receptor, and HER2. Triple-negative cancer is characterized by more aggressive, harder to treat with...
Gardado en:
| Publicado en: | Cell Signal |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2017
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5731460/ https://ncbi.nlm.nih.gov/pubmed/28108260 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cellsig.2017.01.021 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|